Cello Group PLC operates in the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cello Group PLC with three other
miscellaneous service companies in Europe:
Pharma Mar SA
sales of 180.95 million Euro [US$212.38 million]
of which 62%
was Biotech Sector),
Internationella Engelska Skolan I Sverige Holdings II AB
(1.75 billion Swedish Kronor [US$208.20 million]
Hoegh LNG Holdings Ltd
based in Norway
(1.79 billion Norwegian Kroner [US$214.70 million]
of which 65%
Cello Group PLC reported sales of £165.27 million (US$220.06 million)
December of 2016.
increase of 5.1%
versus 2015, when the company's sales were £157.32 million.
Despite this increase, sales are still
below the level achieved in 2014, when Cello Group PLC
reported sales of £169.87 million.
Sales of Unallocated Corporate Expenses saw an increase
that was more than double the company's growth rate: sales were up
68.9% in 2016, from
£994,000.00 to £1.68 million.
Cello Group PLC also saw significant increases in sales in
Cello Health (up 10.3% to £70.13 million)